cilomilast has been researched along with rabeprazole in 3 studies
Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (rabeprazole) | Trials (rabeprazole) | Recent Studies (post-2010) (rabeprazole) |
---|---|---|---|---|---|
162 | 13 | 42 | 1,073 | 446 | 405 |
Protein | Taxonomy | cilomilast (IC50) | rabeprazole (IC50) |
---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | 3.219 | |
Urease subunit alpha | Helicobacter pylori 26695 | 0.29 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 3.219 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.737 | |
D(3) dopamine receptor | Homo sapiens (human) | 2.326 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 3.219 | |
WD repeat-containing protein 5 | Homo sapiens (human) | 0.49 | |
Urease subunit beta | Helicobacter pylori 26695 | 0.29 | |
Histone-lysine N-methyltransferase 2A | Homo sapiens (human) | 0.49 | |
NAD(+) hydrolase SARM1 | Homo sapiens (human) | 3.25 | |
Cytosolic endo-beta-N-acetylglucosaminidase | Homo sapiens (human) | 4.47 | |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 8.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
3 other study(ies) available for cilomilast and rabeprazole
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |